Panacea Biotec Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: PANACEABIO BSE: 531349

₹366.00

Sept. 30, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #79 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	435,863	146.5	13.7%	11.0%	—	72	8	30
Divi's Laboratories Limited	246,660	83.9	15.3%	62.7%	0.32%	70	4	51
Torrent Pharmaceuticals Limited	162,454	78.2	12.2%	34.6%	0.79%	56	0	31
Zydus Lifesciences Limited	115,910	33.3	17.3%	17.2%	0.09%	74	24	84
Cipla Limited	108,736	35.4	11.2%	-11.0%	0.97%	73	29	62
Laurus Labs Limited	106,969	122.5	17.1%	127.1%	—	78	24	53
Mankind Pharma Limited	103,406	47.4	11.7%	2.6%	—	68	12	86
Dr. Reddy's Laboratories Limited	102,916	154.7	10.9%	-0.9%	—	62	33	71
Panacea Biotec Limited (this stock)	2,242	—	-0.9%	-8.7%	—	37	66	46

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹2,504 Cr

EV / EBITDA

215.3x

EV / Sales

5.74x

Market cap / Sales

5.14x

Earnings yield

Data unavailable.

Quarterly Financials

Download CSV

Standalone Consolidated

↑ Positive

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 141 Cr, up 20.1% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	135	2	1	₹0.2300
March 31, 2026	111	-5	-0	₹-0.0300
Dec. 31, 2025	99	-9	-7	₹-1.2000
Sept. 30, 2025	91	-21	-16	₹-2.5500
June 30, 2025	112	-9	-7	₹-1.0900
March 31, 2025	68	-22	-12	₹-2.0200
Dec. 31, 2024	108	10	10	₹1.5800
Sept. 30, 2024	77	1	1	₹0.2100
June 30, 2024	57	-15	-14	₹-2.2500
March 31, 2024	80	-1	-1	₹-0.2200
Dec. 31, 2023	95	1	0	₹0.0700
Sept. 30, 2023	95	3	3	₹0.5200
June 30, 2023	89	1	1	₹0.2100

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Total income (before exceptional items)	141	117	103	94	117	74	112	80	61	97	98	97	93
Operating revenue	135	111	99	91	112	68	108	77	57	80	95	95	89
Other income	6	6	4	4	5	6	3	3	4	16	3	2	3
Operating expenses	127	111	101	105	115	86	93	70	67	90	89	85	83
Operating profit	7	0	-1	-14	-3	-19	15	7	-10	-9	7	10	7
Operating profit margin	5.4%	0.3%	-1.4%	-15.1%	-2.7%	-27.3%	14.2%	8.8%	-18.4%	-11.5%	7.0%	10.5%	7.6%
Depreciation	4	4	5	5	5	5	5	5	5	5	5	5	5
Interest	7	6	7	6	6	5	4	4	3	3	3	4	3
Exceptional items, gain / (loss)	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit before tax	2	-5	-9	-21	-9	-22	10	1	-15	-1	1	3	1
Tax	1	-4	-2	-5	-2	-10	—	0	-1	0	1	—	—
Net profit	1	—	—	—	—	—	10	1	-14	-1	0	3	1
EPS	0.23	-0.03	-1.20	-2.55	-1.09	-2.02	1.58	0.21	-2.25	-0.22	0.07	0.52	0.21
Net profit (TTM)	—	—	—	—	—	—	-4	-13	-12	4	18	11	-67
EPS (TTM)	-3.55	-4.87	-6.86	-4.08	-1.32	-2.48	-0.68	-2.19	-1.88	0.58	2.96	1.77	-10.87

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	413	-44	-30
March 31, 2025	310	-26	-15
March 31, 2024	360	4	4
March 31, 2023	257	-63	-88

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	—	3.4%	431^†	326^†	385^†	—	364^†	189^†	369^†	598^†	582^†
Operating revenue	17.2%	3.8%	413	310	360	257	344^†	158^†	357^†	580^†	530^†
Other income	—	—	18^†	17^†	25^†	—	21^†	31^†	12^†	18^†	52^†
Operating expenses	—	—	431^†	317^†	345^†	—	343^†	220^†	479^†	499^†	385^†
Operating profit	—	—	-18^†	-7^†	14^†	—	0^†	-62^†	-123^†	81^†	145^†
Operating profit margin	—	—	-4.3%^†	-2.2%^†	3.9%^†	—	0.1%^†	-39.4%^†	-34.4%^†	14.0%^†	27.4%^†
Depreciation	—	—	19^†	20^†	21^†	—	27^†	27^†	49^†	57^†	66^†
Interest	—	—	25^†	15^†	14^†	—	8^†	5^†	105^†	103^†	101^†
Exceptional items, gain / (loss)	—	—	0^†	0^†	0^†	—	0^†	-15^†	334^†	0^†	-38^†
Profit before tax	—	—	-44	-26	4	-63	-13^†	-79^†	69^†	-61^†	-84^†
Tax	—	—	-14^†	—	—	—	2^†	17^†	11^†	11^†	—
Net profit	—	—	-30	-15	4	-88	—	—	—	-72^†	-86^†
EPS	—	—	-4.87^†	-2.48^†	0.58^†	—	—	-15.69^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Operating margin	-4.3%^†	-2.2%^†	3.9%^†	—	0.1%^†	-39.4%^†	-34.4%^†	14.0%^†	27.4%^†
EBIT margin	-4.5%^†	-3.4%^†	5.0%^†	—	-1.6%^†	-46.6%^†	48.8%^†	7.2%^†	3.3%^†
PBT margin	-10.6%	-8.4%	1.2%	-24.4%	-3.7%^†	-49.9%^†	19.4%^†	-10.6%^†	-15.8%^†
Net margin	-7.2%	-4.9%	1.0%	-34.1%	—	—	—	-12.4%^†	-16.3%^†
Interest coverage	-0.73x^†	-0.69x^†	1.31x^†	—	-0.71x^†	-13.98x^†	1.66x^†	0.41x^†	0.17x^†
Dividend payout	—	—	0.0%^†	—	—	—	—	—	—
Earnings retention	—	—	100.0%^†	—	—	—	—	—	—
Current ratio	1.00x	0.84x	—	—	—	—	—	—	—
Quick ratio	0.55x	0.40x	—	—	—	—	—	—	—
Debt to equity	0.93x	0.73x	—	—	—	—	—	—	—
Return on equity	-10.5%	-4.9%	—	—	—	—	—	—	—
Return on assets	-3.5%	-1.8%	—	—	—	—	—	—	—
Return on capital employed	-3.3%^†	-2.0%^†	—	—	—	—	—	—	—
Asset turnover	0.49x	0.36x	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	-40	-19	23	34	-74
March 31, 2025	4	-61	90	53	-49
March 31, 2024	37	-51	13	75	-38
March 31, 2023	-11	2	9	38	-49
March 31, 2022	-53	40	10	8	-61

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	852	285	279	19	246	284	285	2	347	126
March 31, 2025	869	314	308	68	161	294	351	38	348	152
March 31, 2024	—	—	—	—	—	—	—	—	—	—
March 31, 2023	—	—	—	—	—	—	—	—	—	—
March 31, 2022	—	—	—	—	—	—	—	—	—	—

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.